Interleukin-6 signalling: more than Jaks and STATs.

The hallmark of signalling by many cytokines is the activation of the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) pathway. However, cytokines additionally activate other pathways. In past years we realised that these pathways significantly contribute to the physiological functions of IL-6 and pathophysiological functions in the context of many inflammatory and proliferative diseases. Whereas other articles in this issue of the European Journal of Cell Biology focus on STAT activation and its regulation we here aim to summarise our knowledge and some remaining questions on interleukin-6 (IL-6)-induced STAT-independent pathways as well as the cross-talk with the Jak/STAT pathway. In the early stages of studying cytokine signalling we were used to analysing individual signalling pathways. These days we know about the importance of both, the crosstalk between pathways initiated by combinations of cytokines as well as the crosstalk between individual pathways initiated by a single cytokine. Whereas the inter-cytokine crosstalk can be studied relatively easily, more sophisticated experimental approaches are required to elucidate the intra-cytokine crosstalk.

[1]  Keigo Nishida,et al.  Gab1 Acts as an Adapter Molecule Linking the Cytokine Receptor gp130 to ERK Mitogen-Activated Protein Kinase , 1998, Molecular and Cellular Biology.

[2]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[3]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[4]  Roger J Daly,et al.  Function, regulation and pathological roles of the Gab/DOS docking proteins , 2009, Cell Communication and Signaling.

[5]  Li Li,et al.  Germline gain-of-function mutations in SOS1 cause Noonan syndrome , 2007, Nature Genetics.

[6]  Fred Schaper,et al.  Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130. , 2006, Cellular signalling.

[7]  D. Cantrell,et al.  STAT3 Is a Serine Kinase Target in T Lymphocytes , 1997, The Journal of Biological Chemistry.

[8]  P. Heinrich,et al.  Signal Transduction of IL-6, Leukemia-Inhibitory Factor, and Oncostatin M: Structural Receptor Requirements for Signal Attenuation1 , 2000, The Journal of Immunology.

[9]  A. Roberts,et al.  The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. , 2005, Blood.

[10]  L. Dekker,et al.  Sequential Activation of Rac-1, SEK-1/MKK-4, and Protein Kinase Cδ Is Required for Interleukin-6-induced STAT3 Ser-727 Phosphorylation and Transactivation* , 2001, The Journal of Biological Chemistry.

[11]  E. Vellenga,et al.  Ser727‐dependent transcriptional activation by association of p300 with STAT3 upon IL‐6 stimulation , 2001, FEBS letters.

[12]  Wei Lu,et al.  Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. , 2001, Molecular cell.

[13]  K. Pfeffer,et al.  Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. , 2003, Immunity.

[14]  B. Neel,et al.  Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2 , 2002, Molecular and Cellular Biology.

[15]  T. Hirano,et al.  STAT3 orchestrates contradictory signals in cytokine‐induced G1 to S cell‐cycle transition , 1998, The EMBO journal.

[16]  M. David,et al.  Rapid STAT Phosphorylation via the B Cell Receptor , 1999, The Journal of Biological Chemistry.

[17]  P. Simister,et al.  Self-Organization and Regulation of Intrinsically Disordered Proteins with Folded N-Termini , 2011, PLoS biology.

[18]  S. Lyonnet,et al.  Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β Signaling , 2010, Molecular and Cellular Biology.

[19]  J. Darnell,et al.  Two contact regions between Stat1 and CBP/p300 in interferon γ signaling , 1996 .

[20]  G. Yancopoulos,et al.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.

[21]  P. Heinrich,et al.  The Cytoplasmic Tyrosine Motifs in Full-Length Glycoprotein 130 Have Different Roles in IL-6 Signal Transduction1 , 2000, The Journal of Immunology.

[22]  R. Mulligan,et al.  Critical Role for Hematopoietic Cell Kinase (Hck)-mediated Phosphorylation of Gab1 and Gab2 Docking Proteins in Interleukin 6-induced Proliferation and Survival of Multiple Myeloma Cells* , 2004, Journal of Biological Chemistry.

[23]  C. Schindler,et al.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. , 1994, Science.

[24]  Pavel Kovarik,et al.  Serine phosphorylation of STATs , 2000, Oncogene.

[25]  M. Baron,et al.  Inhibition of IFN-γ-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP21 , 2008, The Journal of Immunology.

[26]  I. Kerr,et al.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. , 1998, The Biochemical journal.

[27]  J. Scheller,et al.  The IL-6/sIL-6R complex as a novel target for therapeutic approaches , 2007, Expert opinion on therapeutic targets.

[28]  Xinmin Cao,et al.  Serine Phosphorylation and Negative Regulation of Stat3 by JNK* , 1999, The Journal of Biological Chemistry.

[29]  B. Jenkins,et al.  Acquiring signalling specificity from the cytokine receptor gp130. , 2004, Trends in genetics : TIG.

[30]  N. Fausto,et al.  Toll‐like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin‐6 activation in mouse liver regeneration , 2011, Hepatology.

[31]  E. Vellenga,et al.  Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. , 2000, The Biochemical journal.

[32]  G. Feng,et al.  SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei* , 2002, The Journal of Biological Chemistry.

[33]  Boris N Kholodenko,et al.  Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops* , 2006, Journal of Biological Chemistry.

[34]  J. Blenis,et al.  STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation , 1997, Molecular and cellular biology.

[35]  J. G. Zhang,et al.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Heinrich,et al.  SOCS3 Exerts Its Inhibitory Function on Interleukin-6 Signal Transduction through the SHP2 Recruitment Site of gp130* , 2000, The Journal of Biological Chemistry.

[37]  T. Palmer,et al.  Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells , 2006, Molecular and Cellular Biology.

[38]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[39]  C. Trautwein,et al.  Glucagon counteracts interleukin-6-dependent gene expression by redundant action of Epac and PKA , 2011, Biological chemistry.

[40]  H. Baumann,et al.  Protein Tyrosine Phosphatase 2 (SHP-2) Moderates Signaling by gp130 but Is Not Required for the Induction of Acute-Phase Plasma Protein Genes in Hepatic Cells , 1998, Molecular and Cellular Biology.

[41]  W. Muller,et al.  Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation* , 2006, Journal of Biological Chemistry.

[42]  S. Feller,et al.  PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors , 2004, BMC Biology.

[43]  G. Stark,et al.  Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.

[44]  J. Kovarik,et al.  Listeria monocytogenes Modulates Macrophage Cytokine Responses Through STAT Serine Phosphorylation and the Induction of Suppressor of Cytokine Signaling 31 , 2001, The Journal of Immunology.

[45]  Jens Schneider-Mergener,et al.  SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130* , 2003, The Journal of Biological Chemistry.

[46]  H. Kim,et al.  The Carboxyl-terminal Region of STAT3 Controls Gene Induction by the Mouse Haptoglobin Promoter* , 1997, The Journal of Biological Chemistry.

[47]  G. Feng,et al.  Syp Associates with gp130 and Janus Kinase 2 in Response to Interleukin-11 in 3T3-L1 Mouse Preadipocytes (*) , 1995, The Journal of Biological Chemistry.

[48]  Xin-Yuan Fu,et al.  Negative Regulation of Stat3 by Activating PTPN11 Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia* , 2009, The Journal of Biological Chemistry.

[49]  R. Wetzker,et al.  A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins , 2000, Current Biology.

[50]  S. Koyasu.  The role of PI3K in immune cells , 2003, Nature Immunology.

[51]  A new mechanism for the regulation of Gab1 recruitment to the plasma membrane , 2009, Journal of Cell Science.

[52]  Thomas Edouard,et al.  Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition , 2007, Molecular and Cellular Biology.

[53]  M. Mihailović,et al.  Acute-phase protein expression in DMSO-intoxicated rats. , 2004, Toxicology letters.

[54]  J. Downward,et al.  Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor , 1999, Molecular and Cellular Biology.

[55]  P. Cole,et al.  Chemical dissection of the effects of tyrosine phosphorylation of SHP-2. , 2003, Biochemistry.

[56]  B. Parfait,et al.  How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms? , 2007, Cellular and Molecular Life Sciences.

[57]  M. Manns,et al.  Interleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration* , 2003, The Journal of Biological Chemistry.

[58]  L. Cantley,et al.  Conditional Inhibition of the Mitogen-activated Protein Kinase Cascade by Wortmannin , 1997, The Journal of Biological Chemistry.

[59]  M. Karin,et al.  Autocrine IL-6 signaling: a key event in tumorigenesis? , 2008, Cancer cell.

[60]  G. Stark,et al.  A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin‐6. , 1995, The EMBO journal.

[61]  T. Hirano,et al.  IL-6 signal transduction and its physiological roles: the signal orchestration model. , 2003, Reviews of physiology, biochemistry and pharmacology.

[62]  J. Salles,et al.  A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation* , 2005, Journal of Biological Chemistry.

[63]  D. Barford,et al.  PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects* , 2006, Journal of Biological Chemistry.

[64]  P. Heinrich,et al.  Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation. , 2008, The Biochemical journal.

[65]  J. Darnell,et al.  Essential Role of STAT3 in Postnatal Survival and Growth Revealed by Mice Lacking STAT3 Serine 727 Phosphorylation , 2004, Molecular and Cellular Biology.

[66]  T. Nheu,et al.  Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling , 2005, Nature Medicine.

[67]  H. Park,et al.  Extracellular Signal-regulated Kinase Activation Is Required for Serine 727 Phosphorylation of STAT3 in Schwann Cells in vitro and in vivo. , 2009, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[68]  M. Warmuth,et al.  Signaling through a Novel Domain of gp130 Mediates Cell Proliferation and Activation of Hck and Erk Kinases , 2001, Molecular and Cellular Biology.

[69]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[70]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[71]  Jens Timmer,et al.  Systems-level interactions between insulin–EGF networks amplify mitogenic signaling , 2009, Molecular systems biology.

[72]  I. Behrmann,et al.  Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases , 2010, Journal of cellular and molecular medicine.

[73]  S. Rose-John,et al.  A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain , 2009, The Journal of Neuroscience.

[74]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[75]  T. Hirano,et al.  The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway , 2001, Oncogene.

[76]  Michiko Furutani,et al.  Germline gain-of-function mutations in RAF1 cause Noonan syndrome , 2007, Nature Genetics.

[77]  J. Darnell,et al.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[78]  H. Baumann,et al.  The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells* , 1999, The Journal of Biological Chemistry.

[79]  N. Tonks,et al.  A Critical Role for Phosphoinositide 3-Kinase Upstream of Gab1 and SHP2 in the Activation of Ras and Mitogen-activated Protein Kinases by Epidermal Growth Factor* , 2001, The Journal of Biological Chemistry.

[80]  A. Roberts,et al.  Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. , 2007, Blood.

[81]  J. Darnell,et al.  Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[82]  G. Yancopoulos,et al.  The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression , 1997, Current Biology.

[83]  N. Droin,et al.  Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection , 2006, Molecular and Cellular Biology.

[84]  Tong Zhang,et al.  Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner* , 1999, The Journal of Biological Chemistry.

[85]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[86]  B. Jenkins,et al.  Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. , 2004, Gastroenterology.

[87]  M. Baron,et al.  Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. , 2008, Journal of immunology.

[88]  Axel Wollmer,et al.  Differential Activation of Acute Phase Response Factor/Stat3 and Stat1 via the Cytoplasmic Domain of the Interleukin 6 Signal Transducer gp130 , 1996, The Journal of Biological Chemistry.

[89]  R. Wetzker,et al.  A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins , 2000, Current Biology.

[90]  J. Scheller,et al.  The pro- and anti-inflammatory properties of the cytokine interleukin-6. , 2011, Biochimica et biophysica acta.

[91]  B. Jenkins,et al.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.

[92]  Bruce D Gelb,et al.  Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. , 2006, Human molecular genetics.

[93]  B. Gelb,et al.  Germ-line and somatic PTPN11 mutations in human disease. , 2005, European journal of medical genetics.

[94]  Jens Schneider-Mergener,et al.  Differential Activation of Acute Phase Response Factor/STAT3 and STAT1 via the Cytoplasmic Domain of the Interleukin 6 Signal Transducer gp130 , 1996, The Journal of Biological Chemistry.

[95]  Oren Shoval,et al.  SnapShot: Network Motifs , 2010, Cell.

[96]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.